Nymalize, a calcium channel blocker, is indicated for which of the following?
d. Subarachnoid hemorrhage
Nymalize contains Nimodipine, a dihydropyridine calcium channel blocker. An oral solution of Nymalize contains 60 mg of Nimodipine per 20 mL.
It is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).
The recommended oral dosage is 20 mL (60 mg) every 4 hours for 21 consecutive days.
Hypotension is the major side effect of Nymalize.